Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + remifentanil vs remimazolam + remifentanil for sedation during gastric ESD
KCT0008517Phase 4Recruiting
- Sponsor
- Konkuk University Medical Center
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, remimazolam in benign neoplasm of stomach, gastric cancer (GC), sponsored by Konkuk University Medical Center. Started May 2023; status: recruiting.
02
Drugs
dexmedetomidineremimazolam
03
Conditions
benign neoplasm of stomachgastric cancer (GC)
Beyond the preview
Go deeper on KCT0008517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008517.